Seth Rakoff-Nahoum, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Symbiosis | 7 | 2021 | 297 | 2.110 |
Why?
|
Microbial Interactions | 3 | 2021 | 74 | 1.350 |
Why?
|
Intestines | 7 | 2016 | 1906 | 1.160 |
Why?
|
Toll-Like Receptors | 7 | 2015 | 582 | 1.080 |
Why?
|
Immunity, Innate | 8 | 2024 | 3078 | 0.780 |
Why?
|
Polysaccharides | 2 | 2022 | 1017 | 0.760 |
Why?
|
Biological Evolution | 2 | 2017 | 1075 | 0.720 |
Why?
|
Biodiversity | 2 | 2021 | 344 | 0.710 |
Why?
|
Bacteroidetes | 2 | 2022 | 84 | 0.630 |
Why?
|
Mammals | 2 | 2022 | 1126 | 0.570 |
Why?
|
Intestinal Mucosa | 6 | 2016 | 3048 | 0.520 |
Why?
|
Bacteroides | 1 | 2016 | 165 | 0.500 |
Why?
|
Immunity, Maternally-Acquired | 1 | 2016 | 112 | 0.500 |
Why?
|
Ecosystem | 2 | 2017 | 489 | 0.500 |
Why?
|
Metabolome | 1 | 2022 | 1005 | 0.470 |
Why?
|
Infant, Premature | 2 | 2021 | 2121 | 0.460 |
Why?
|
Epithelium | 2 | 2020 | 1603 | 0.460 |
Why?
|
Fucose | 1 | 2014 | 115 | 0.450 |
Why?
|
Immune System | 3 | 2016 | 799 | 0.420 |
Why?
|
Myeloid Differentiation Factor 88 | 4 | 2008 | 582 | 0.360 |
Why?
|
Peptic Ulcer | 2 | 2024 | 214 | 0.360 |
Why?
|
Regeneration | 3 | 2008 | 1516 | 0.350 |
Why?
|
Intestine, Small | 2 | 2014 | 1216 | 0.340 |
Why?
|
Cell Transformation, Neoplastic | 3 | 2008 | 2838 | 0.340 |
Why?
|
Disease | 1 | 2014 | 674 | 0.320 |
Why?
|
Endogenous Retroviruses | 2 | 2007 | 111 | 0.300 |
Why?
|
ABO Blood-Group System | 3 | 2024 | 381 | 0.290 |
Why?
|
Bacteria | 4 | 2023 | 2210 | 0.280 |
Why?
|
Adaptive Immunity | 2 | 2020 | 733 | 0.280 |
Why?
|
Homeostasis | 6 | 2016 | 3338 | 0.280 |
Why?
|
Prostaglandins | 1 | 2007 | 396 | 0.250 |
Why?
|
Species Specificity | 2 | 2022 | 2406 | 0.250 |
Why?
|
Models, Biological | 4 | 2018 | 9443 | 0.240 |
Why?
|
Intestinal Neoplasms | 1 | 2007 | 314 | 0.230 |
Why?
|
Seminoma | 1 | 2006 | 135 | 0.230 |
Why?
|
Galectins | 2 | 2024 | 293 | 0.230 |
Why?
|
Lymphoid Tissue | 1 | 2006 | 444 | 0.230 |
Why?
|
Galectin 4 | 1 | 2024 | 36 | 0.220 |
Why?
|
Neurogenic Inflammation | 1 | 2023 | 34 | 0.210 |
Why?
|
Amylases | 1 | 2023 | 171 | 0.210 |
Why?
|
Coenzyme A-Transferases | 1 | 2022 | 7 | 0.200 |
Why?
|
Animals | 21 | 2024 | 168735 | 0.200 |
Why?
|
T-Lymphocytes | 4 | 2021 | 10256 | 0.200 |
Why?
|
Acyl Coenzyme A | 1 | 2022 | 56 | 0.200 |
Why?
|
Butyrates | 1 | 2022 | 164 | 0.180 |
Why?
|
Neurons, Afferent | 1 | 2023 | 496 | 0.180 |
Why?
|
Vaginosis, Bacterial | 1 | 2022 | 154 | 0.180 |
Why?
|
Pericytes | 1 | 2023 | 299 | 0.180 |
Why?
|
Bacterial Load | 1 | 2021 | 156 | 0.170 |
Why?
|
HLA-DR Antigens | 1 | 2001 | 608 | 0.170 |
Why?
|
Anti-Ulcer Agents | 1 | 2020 | 112 | 0.160 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2022 | 266 | 0.160 |
Why?
|
Histamine H2 Antagonists | 1 | 2020 | 168 | 0.160 |
Why?
|
Inflammatory Bowel Diseases | 2 | 2010 | 2430 | 0.160 |
Why?
|
Inflammation | 4 | 2020 | 10843 | 0.150 |
Why?
|
Severe Combined Immunodeficiency | 1 | 2021 | 235 | 0.150 |
Why?
|
Bacterial Toxins | 1 | 2023 | 924 | 0.150 |
Why?
|
Paneth Cells | 1 | 2018 | 99 | 0.150 |
Why?
|
Colitis | 1 | 2006 | 1239 | 0.150 |
Why?
|
Host-Pathogen Interactions | 2 | 2016 | 1463 | 0.140 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2022 | 2476 | 0.140 |
Why?
|
B-Lymphocytes | 2 | 2021 | 4782 | 0.140 |
Why?
|
Gastrointestinal Hemorrhage | 2 | 2024 | 1127 | 0.140 |
Why?
|
D-Amino-Acid Oxidase | 1 | 2016 | 24 | 0.130 |
Why?
|
Neoplasm Proteins | 1 | 2008 | 3592 | 0.130 |
Why?
|
Inulin | 1 | 2016 | 67 | 0.130 |
Why?
|
Host Specificity | 1 | 2016 | 56 | 0.130 |
Why?
|
Glycoside Hydrolases | 1 | 2016 | 135 | 0.130 |
Why?
|
Germ-Free Life | 1 | 2016 | 187 | 0.130 |
Why?
|
Heart Defects, Congenital | 2 | 2024 | 4712 | 0.120 |
Why?
|
Receptors, Cell Surface | 1 | 2004 | 2814 | 0.120 |
Why?
|
Bacterial Adhesion | 1 | 2016 | 305 | 0.120 |
Why?
|
Neoplasms | 3 | 2008 | 22340 | 0.120 |
Why?
|
Signal Transduction | 6 | 2023 | 23597 | 0.120 |
Why?
|
Peripheral Nervous System | 1 | 2015 | 151 | 0.120 |
Why?
|
Lymphocyte Activation | 2 | 2021 | 5500 | 0.110 |
Why?
|
Stress, Physiological | 1 | 2022 | 1404 | 0.110 |
Why?
|
Health | 1 | 2017 | 397 | 0.110 |
Why?
|
Antibodies, Viral | 1 | 2006 | 3213 | 0.110 |
Why?
|
Receptors, Interleukin-1 | 1 | 2015 | 260 | 0.110 |
Why?
|
Membrane Glycoproteins | 1 | 2004 | 3690 | 0.110 |
Why?
|
Neuroimmunomodulation | 1 | 2015 | 186 | 0.110 |
Why?
|
Immunologic Memory | 1 | 2020 | 1374 | 0.100 |
Why?
|
Immunity, Mucosal | 1 | 2016 | 498 | 0.100 |
Why?
|
Mice | 9 | 2023 | 81782 | 0.100 |
Why?
|
Interleukin-10 | 2 | 2008 | 1181 | 0.100 |
Why?
|
Organoids | 1 | 2018 | 740 | 0.100 |
Why?
|
Monocytes | 1 | 2001 | 2591 | 0.100 |
Why?
|
Gestational Age | 1 | 2021 | 3616 | 0.100 |
Why?
|
Mutation, Missense | 1 | 2021 | 2589 | 0.090 |
Why?
|
Dietary Carbohydrates | 1 | 2016 | 896 | 0.090 |
Why?
|
Promoter Regions, Genetic | 1 | 2022 | 5784 | 0.090 |
Why?
|
Amino Acid Sequence | 1 | 2022 | 13398 | 0.090 |
Why?
|
Amino Acids | 1 | 2016 | 1709 | 0.090 |
Why?
|
Humans | 28 | 2024 | 765926 | 0.080 |
Why?
|
Mice, Knockout | 3 | 2015 | 14450 | 0.080 |
Why?
|
Ligands | 2 | 2008 | 3272 | 0.080 |
Why?
|
Apoptosis | 2 | 2021 | 9505 | 0.080 |
Why?
|
Immunologic Surveillance | 1 | 2008 | 92 | 0.070 |
Why?
|
Transcription, Genetic | 1 | 2022 | 7599 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2020 | 3684 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2016 | 1387 | 0.070 |
Why?
|
Intestine, Large | 1 | 2007 | 69 | 0.070 |
Why?
|
Vagina | 2 | 2023 | 849 | 0.070 |
Why?
|
Genes, APC | 1 | 2007 | 144 | 0.070 |
Why?
|
Single-Cell Analysis | 1 | 2018 | 2536 | 0.070 |
Why?
|
Genetic Variation | 1 | 2022 | 6612 | 0.070 |
Why?
|
HIV-1 | 2 | 2007 | 6945 | 0.060 |
Why?
|
Infant | 3 | 2024 | 36426 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2006 | 2897 | 0.060 |
Why?
|
Macrophages | 1 | 2020 | 5772 | 0.060 |
Why?
|
Infant, Newborn | 2 | 2021 | 26380 | 0.060 |
Why?
|
Virus Integration | 1 | 2006 | 303 | 0.050 |
Why?
|
Molecular Mimicry | 1 | 2024 | 210 | 0.050 |
Why?
|
Antigens, Viral | 1 | 2007 | 995 | 0.050 |
Why?
|
Receptors, Neurokinin-1 | 1 | 2023 | 133 | 0.050 |
Why?
|
Fibronectins | 1 | 2006 | 720 | 0.050 |
Why?
|
Cecum | 1 | 2023 | 231 | 0.050 |
Why?
|
Glycogen | 1 | 2023 | 252 | 0.050 |
Why?
|
Diet | 1 | 2021 | 8087 | 0.050 |
Why?
|
Computational Biology | 1 | 2015 | 3562 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 20133 | 0.050 |
Why?
|
Ulcer | 1 | 2024 | 202 | 0.050 |
Why?
|
Blood Group Antigens | 1 | 2024 | 183 | 0.050 |
Why?
|
Substance P | 1 | 2023 | 331 | 0.050 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2022 | 16039 | 0.050 |
Why?
|
Genes, Tumor Suppressor | 1 | 2006 | 1060 | 0.050 |
Why?
|
Dendritic Cells | 2 | 2020 | 2745 | 0.050 |
Why?
|
Genomics | 1 | 2018 | 5925 | 0.050 |
Why?
|
Female | 8 | 2023 | 396141 | 0.050 |
Why?
|
Y-Box-Binding Protein 1 | 1 | 2001 | 41 | 0.050 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2004 | 656 | 0.050 |
Why?
|
HLA-D Antigens | 1 | 2001 | 130 | 0.050 |
Why?
|
NFI Transcription Factors | 1 | 2001 | 49 | 0.050 |
Why?
|
Antigens, Differentiation | 1 | 2004 | 919 | 0.050 |
Why?
|
Coatomer Protein | 1 | 2021 | 18 | 0.050 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2001 | 151 | 0.050 |
Why?
|
Th1 Cells | 1 | 2006 | 1040 | 0.050 |
Why?
|
Cell Death | 1 | 2006 | 1676 | 0.050 |
Why?
|
U937 Cells | 1 | 2001 | 259 | 0.050 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2001 | 317 | 0.040 |
Why?
|
Cell Compartmentation | 1 | 2001 | 383 | 0.040 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2023 | 331 | 0.040 |
Why?
|
HIV Antigens | 1 | 2001 | 328 | 0.040 |
Why?
|
Isoantibodies | 1 | 2024 | 681 | 0.040 |
Why?
|
T-Lymphocyte Subsets | 1 | 2008 | 1812 | 0.040 |
Why?
|
Protein Binding | 2 | 2024 | 9296 | 0.040 |
Why?
|
Genes, MHC Class II | 1 | 2001 | 433 | 0.040 |
Why?
|
Heat-Shock Proteins | 1 | 2004 | 790 | 0.040 |
Why?
|
Male | 6 | 2021 | 363815 | 0.040 |
Why?
|
Hybridomas | 1 | 2001 | 442 | 0.040 |
Why?
|
Neurons | 2 | 2020 | 9527 | 0.040 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 1 | 2001 | 287 | 0.040 |
Why?
|
Interleukin-2 | 1 | 2006 | 1894 | 0.040 |
Why?
|
Cell Division | 1 | 2007 | 4466 | 0.040 |
Why?
|
Receptors, Peptide | 1 | 2021 | 280 | 0.040 |
Why?
|
Critical Illness | 2 | 2024 | 2749 | 0.040 |
Why?
|
Golgi Apparatus | 1 | 2021 | 405 | 0.040 |
Why?
|
Protein Multimerization | 1 | 2024 | 959 | 0.040 |
Why?
|
Pregnancy | 2 | 2022 | 30230 | 0.040 |
Why?
|
Pilot Projects | 2 | 2024 | 8724 | 0.040 |
Why?
|
Immunotherapy, Adoptive | 1 | 2008 | 1504 | 0.040 |
Why?
|
Cytokines | 2 | 2022 | 7417 | 0.040 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2022 | 426 | 0.040 |
Why?
|
Immunity | 1 | 2004 | 1000 | 0.040 |
Why?
|
Enterocolitis, Pseudomembranous | 1 | 2020 | 264 | 0.040 |
Why?
|
NF-kappa B | 1 | 2006 | 2492 | 0.040 |
Why?
|
Receptors, Immunologic | 1 | 2004 | 1415 | 0.040 |
Why?
|
Mice, Mutant Strains | 1 | 2021 | 1748 | 0.040 |
Why?
|
Wound Healing | 1 | 2008 | 2794 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2001 | 1440 | 0.030 |
Why?
|
DNA Damage | 1 | 2006 | 2462 | 0.030 |
Why?
|
Clostridium Infections | 1 | 2023 | 563 | 0.030 |
Why?
|
Immunoglobulin A, Secretory | 1 | 2016 | 105 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2024 | 985 | 0.030 |
Why?
|
Plasma Cells | 1 | 2020 | 596 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1740 | 0.030 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.030 |
Why?
|
Colon | 1 | 2004 | 1796 | 0.030 |
Why?
|
Protein Transport | 1 | 2001 | 1938 | 0.030 |
Why?
|
Colonic Neoplasms | 1 | 2007 | 2530 | 0.030 |
Why?
|
Bacterial Physiological Phenomena | 1 | 2016 | 120 | 0.030 |
Why?
|
Stem Cell Niche | 1 | 2018 | 347 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2021 | 1132 | 0.030 |
Why?
|
Inflammation Mediators | 1 | 2023 | 1886 | 0.030 |
Why?
|
Cell Movement | 1 | 2006 | 5190 | 0.030 |
Why?
|
Stromal Cells | 1 | 2020 | 1332 | 0.030 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2007 | 4641 | 0.030 |
Why?
|
Stem Cells | 1 | 2007 | 3537 | 0.030 |
Why?
|
Transfection | 1 | 2001 | 5738 | 0.030 |
Why?
|
Goblet Cells | 1 | 2016 | 300 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 740 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2016 | 1042 | 0.020 |
Why?
|
Escherichia coli | 1 | 2024 | 4210 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2007 | 10426 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2007 | 8603 | 0.020 |
Why?
|
Cross Infection | 1 | 2020 | 1426 | 0.020 |
Why?
|
Cell Lineage | 1 | 2020 | 2573 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2018 | 2036 | 0.020 |
Why?
|
Vibrio cholerae | 1 | 2016 | 793 | 0.020 |
Why?
|
Aging | 1 | 2008 | 8725 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2021 | 3560 | 0.020 |
Why?
|
Mice, Inbred C57BL | 1 | 2007 | 22327 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2004 | 18962 | 0.020 |
Why?
|
Pneumonia | 1 | 2020 | 2158 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2007 | 18292 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3799 | 0.020 |
Why?
|
Nuclear Proteins | 1 | 2001 | 5782 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2020 | 12417 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2006 | 18074 | 0.010 |
Why?
|
Proteomics | 1 | 2018 | 3906 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2001 | 9600 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2001 | 11895 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2020 | 10380 | 0.010 |
Why?
|
Transcription Factors | 1 | 2001 | 12129 | 0.010 |
Why?
|
HIV Infections | 1 | 2007 | 17531 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4563 | 0.010 |
Why?
|
RNA, Viral | 1 | 2007 | 2866 | 0.010 |
Why?
|
Viral Load | 1 | 2007 | 3385 | 0.010 |
Why?
|
Flow Cytometry | 1 | 2007 | 5880 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2024 | 65194 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54807 | 0.010 |
Why?
|
Middle Aged | 1 | 2006 | 223016 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2007 | 26282 | 0.000 |
Why?
|
Cohort Studies | 1 | 2007 | 41680 | 0.000 |
Why?
|